B
Baha'uddin M. Arafah
Researcher at Case Western Reserve University
Publications - 33
Citations - 1957
Baha'uddin M. Arafah is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Prolactin & Tamoxifen. The author has an hindex of 22, co-authored 33 publications receiving 1906 citations. Previous affiliations of Baha'uddin M. Arafah include University Hospitals of Cleveland.
Papers
More filters
Journal ArticleDOI
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Ernest L. Mazzaferri,Richard J. Robbins,Carole A. Spencer,Lewis E. Braverman,Furio Pacini,Leonard Wartofsky,Bryan R. Haugen,Steven I. Sherman,David S. Cooper,Glenn D. Braunstein,Stephanie L. Lee,Terry F. Davies,Baha'uddin M. Arafah,Paul W. Ladenson,Aldo Pinchera +14 more
TL;DR: A surveillance guideline is proposed using TSH-stimulated Tg levels for patients who have undergone total or near-total thyroidectomy and (131)I ablation for DTC and have no clinical evidence of residual tumor with a serum Tg below 1 micro g/liter during THST.
Journal ArticleDOI
Reversible Hypopituitarism in Patients with Large Nonfunctioning Pituitary Adenomas
TL;DR: It is suggested that compression of the portal circulation is a possible mechanism for hypopituitarism in this setting and significant improvement in pituitsary function may occur after surgical adenomectomy for nonsecreting pituitary tumors.
Journal ArticleDOI
Improvement of Pituitary Function after Surgical Decompression for Pituitary Tumor Apoplexy
TL;DR: The rapid improvement in pituitary function indicates not only that the hypopituitarism was reversible, but also that it might be caused by compression of the portal circulation and pituitsary stalk by the sudden increase in intrasellar contents.
Journal ArticleDOI
Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.
TL;DR: In the experience, limited to a small number of patients, the presence of PgR in addition to ER did not increase the probability of response to endocrine therapy and underscore the usefulness of ER measurement in the prediction of Response to either antiestrogen therapy or hypophysectomy in metastatic breast cancer.
Journal ArticleDOI
Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
Baha'uddin M. Arafah,Jerald S. Brodkey,Benjamin Kaufman,Manuel E. Velasco,Andrea Manni,Olof H. Pearson +5 more
TL;DR: Transsphenoidal microsurgery is an optimal form of therapy for patients with acromegaly or gigantism, especially those with no extrasellar extension,especially those withNo extraseLLar extension.